1. انتشارات جعفری نوین
  2. لاتین
  3. خون و سرطان - Hematology & Oncology
  4. Management of Chemotherapy-Induced Nausea and Vomiting : New Agents and New Uses of Current Agents
Management of Chemotherapy-Induced Nausea and Vomiting : New Agents and New Uses of Current Agents Springer
Management of Chemotherapy-Induced Nausea and Vomiting : New Agents and New Uses of Current Agents Springer Springer  

Management of Chemotherapy-Induced Nausea and Vomiting : New Agents and New Uses of Current Agents

کد کتاب 143213

Management of Chemotherapy-Induced Nausea and Vomiting : New Agents and New Uses of Current Agents2016

مدیریت تهوع و استفراغ ناشی از شیمی درمانی: عوامل جدید و استفاده های جدید از عوامل فعلی

افست = اورجینال
چاپ تمام رنگی

کاغذ 80 گرمی اندونزی
جلد سخت / ته دوخت / سیمی

*بهترین کیفیت افست را از ما بخواهید*

این کتاب یک مرور جامع از عوامل جدید ، شرح مفصلی از کاربردهای جدید داروهای فعلی و ادغام عوامل موجود در عمل بالینی را ارائه می دهد. این کار اولین خلاصه جامع موجود است که تمام عوامل ضد استفراغ جدید و به ویژه نقش بالینی آنها در درمان بیماران را توضیح می دهد. یک مرجع مهم برای پزشکانی که به دنبال بهبود کیفیت زندگی بیماران تحت شیمی درمانی هستند.

تعداد صفحه
181
چاپ
زبان
سال نشر
شابک
قطع
نوبت چاپ

خرید Management of Chemotherapy-Induced Nausea and Vomiting : New Agents and New Uses of Current Agents

دارای 5% تخفیف  

Management of Chemotherapy-Induced Nausea and Vomiting : New Agents and New Uses of Current Agents2016

مدیریت تهوع و استفراغ ناشی از شیمی درمانی: عوامل جدید و استفاده های جدید از عوامل فعلی

This book provides a comprehensive review of new agents, a detailed description of new uses of current agents, and an integration of the available agents in clinical practice. A description of a detailed clinical approach provides clinical practitioners with the most up-to-date recommendations for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) in various clinical settings.
CINV is one of the most feared treatment related toxicities. Patient surveys for the past thirty years consistently demonstrate patients' perception of deterioration in quality of life due to chemotherapy treatments. The introduction of the antiemetics, serotonin 5-HT3 receptor antagonists and the neurokinin-1 receptor antagonists, have improved the control of chemotherapy-induced emesis, but the treatment of chemotherapy-induced nausea remains a significant clinical problem. Patients continue to have quality of life issues which prevent normal functioning during active treatment. New agents such as the second generation 5-HT3 receptor antagonist palonosetron and the new neuroknin-1 receptor antagonists rolapitant and netupitant are being introduced into clinical practice, and it is anticipated that these new agents will improve the control of CINV. Agents such as olanzapine (a FDA approved anti-psychotic), gabapentin (a FDA approved neuroleptic), and ginger (a food additive), which have been used primarily for other indications, are now being tested as potential, effective antiemetics.
This work represents the first available comprehensive summary that details all new antiemetic agents and, particularly, their clinical role in treating patients; an important reference for practitioners seeking to improve the quality of life of patients undergoing chemotherapy.
show less

Product details

  • Hardback | 181 pages
  • 155 x 235 x 16.26mm | 4,136g
  • Adis
  • Cham, Switzerland
  • English
  • 1st ed. 2016
  • 8 Tables, color; 7 Tables, black and white; 8 Illustrations, color; 9 Illustrations, black and white; VIII, 181 p. 17 illus., 8 illus. in color.
  • 3319270141
  • 9783319270142